The increased demands of small-diameter vascular grafts (SDVGs) globally has forced the
scientific society to explore alternative strategies utilizing the tissue engineering …

Decellularization of tissues and organs has recently become a promising approach in tissue
engineering and regenerative medicine to circumvent the challenges of organ donation and …

Pathologies related to the cardiovascular system are the leading causes of death worldwide.
One of the main treatments is conventional surgery with autologous transplants. Although …

The functionalization of decellularized scaffolds is still challenging because of the
recellularization-related limitations, including the finding of the most optimal kind of cell (s) …

The concept of tissue engineering evolved long before the phrase was forged, driven by the
thromboembolic complications associated with the early total artificial heart programs of the …

Vascular disease in elderly patients is a growing health concern, with an estimated
prevalence of 15–20% in patients above 70 years old. Current treatment for vascular …

The incidence rate of cardiovascular diseases is increasing year by year. The demand for
coronary artery bypass grafting has been very large. Acellular blood vessels have potential …

Human saphenous vein (hSV) and synthetic grafts are commonly used conduits in vascular
grafting, despite high failure rates. Decellularising hSVs (D-hSVs) to produce vascular …

BACKGROUND: Renal dysfunction remains a global issue, with chronic kidney disease
being the 18th most leading cause of death, worldwide. The increased demands in kidney …

Cardiovascular disease is one of the main causes of mortality and morbidity worldwide. The
“gold standard” for the replacement/repair of diseased blood vessels is substitution with …